#vaccine-effectiveness

[ follow ]
time.com
2 weeks ago
Coronavirus

Health Experts are Watching a More Dangerous Version of Mpox

Cases of new, severe mpox viruses rising in Central Africa, posing global threat. [ more ]
#covid-19
Los Angeles Times
3 weeks ago
Coronavirus

There's a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?

Two new COVID-19 subvariants, FLiRT (KP.2 and KP.1.1), are 20% more transmissible than the previous JN.1 variant. FLiRT dominates infections, causing a possible summer uptick. [ more ]
Cbsnews
3 months ago
Public health

COVID variant JN.1 now more than 90% of cases in U.S., CDC estimates

The JN.1 variant is responsible for nearly all new COVID-19 cases in the United States, accounting for 93.1% of infections.
Key indicators are showing signs of decreasing COVID-19 activity nationally. [ more ]
News
5 months ago
Public health

Walensky shares public health lessons she learned as CDC director

COVID-19 vaccine effectiveness was a major challenge during Walensky's tenure as CDC director.
Combining health data from different systems poses challenges for determining vaccine effectiveness. [ more ]
morecovid-19
#covid-19-vaccine
www.dw.com
3 weeks ago
Coronavirus

AstraZeneca withdraws COVID-19 vaccine citing low demand DW 05/08/2024

AstraZeneca has withdrawn its COVID-19 vaccine Vaxzevria globally due to declining demand and the availability of other updated vaccines. [ more ]
time.com
3 months ago
Health

Why Older Adults Need Another COVID-19 Shot

Older adults should receive an additional COVID-19 vaccine dose for added protection.
Data supports the effectiveness of the additional vaccine dose in reducing hospitalizations among seniors. [ more ]
www.nytimes.com
3 months ago
Public health

Older Americans Should Get Another Covid Shot This Spring, Panel Says

Older Americans advised to get a spring Covid vaccine dose
Second dose for older adults beneficial [ more ]
time.com
4 months ago
Public health

The New COVID-19 Shot Is Surprisingly Effective Against the Latest Variant

The latest COVID-19 vaccine is about 54% effective at protecting people from symptoms of COVID-19, according to a report from the CDC.
The vaccine is 49% effective at protecting against symptoms from the JN.1 variant, despite being designed to target a different variant. [ more ]
www.mercurynews.com
4 months ago
Public health

Latest Covid-19 vaccine offers strong protection against symptomatic infection, including from JN.1, early CDC data shows

The latest Covid-19 vaccines show 54% protection against symptomatic infection.
The vaccines are effective against the Omicron variant and the JN.1 strain. [ more ]
morecovid-19-vaccine
www.nytimes.com
1 month ago
Coronavirus

The Side Effects of Covid Vaccines

The benefits of Covid vaccines outweigh the downsides despite some reported serious side effects. [ more ]
www.theguardian.com
2 months ago
Health

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Covid vaccinations reduce heart failure and blood clot risks
Vaccines by Oxford-AstraZeneca, Pfizer, and Moderna effective [ more ]
Cbsnews
3 months ago
Public health

CDC finds flu shots 42% effective this season, better than some recent years

This season's flu vaccines are 42% effective, matching past years' effectiveness.
Vaccines target four different flu subtypes, with effectiveness ranging from 52% to 61% for children and 41% to 44% for adults. [ more ]
www.npr.org
3 months ago
Public health

Older US adults should get another COVID-19 shot, health officials recommend

Older adults should get Comirnaty booster if 4 months passed since last shot
CDC recommends another COVID-19 shot for added protection in high-risk elderly [ more ]
Ars Technica
5 months ago
Public health

Texas sues Pfizer with COVID anti-vax argument that is pure stupid

Texas Attorney General Ken Paxton has sued Pfizer, alleging that the company deceived the public and misrepresented the effectiveness of its COVID-19 vaccine.
Paxton's lawsuit relies on flawed arguments about the math used to assess the vaccine's effectiveness, which has been debunked by experts. [ more ]
[ Load more ]